{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T08:04:01Z","timestamp":1788595441118,"version":"build-2803163510"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"35","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9,1]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The purpose of this study was to explore efficacy of locally injected tranexamic acid (TXA) at a concentration of 1\u2009mg\/mL for reduction perioperative bleeding and postoperative complications in subcutaneous tumor excisions. We present the protocol and also compare results between the group of use antithrombotic group and not used.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This is a retrospective study. Fifty-three patients were divided into 3 groups. Group 1 (n = 14): using antithrombotic drugs (antiplatelet or anticoagulants) with locally injected TXA. Group 2 (n = 17): using antithrombotic drugs without locally injected TXA. Group 3 (n = 22): not using antithrombotic drugs but with locally injected TXA. TXA was diluted to 1\u2009mg\/mL for use based on our experience. All patients were operated by 1 surgeon in 1 single medical center in Taipei from March 1st, 2020, to March 31st 2022. Outcomes such as the quality of perioperative surgical field and postoperative surgical complications were evaluated and compared. The quality of field was intraoperatively recorded by an assessment and photos from the surgeon. The statistical relationships between the complication rates were analyzed using \u03c72 test and a 1-way ANOVA by SPSS 25.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>From Groups 1 and 3, a total of 36 patients, 29 patients had a clear surgical field during procedure. When comparing Groups 1 and 2, use of locally injected TXA had greater positive advantage in terms of a clearer vision whilst surgery (<jats:italic toggle=\"yes\">P<\/jats:italic> = .031). Group 2 had more minor complications such as hematoma, severe ecchymosis, wound dehiscence, wound infection. By postoperatively reducing hematomas for 24 hours, it significantly reduce the incidence of abovementioned minor complications (<jats:italic toggle=\"yes\">P<\/jats:italic> = .036). With the help of locally injected TXA, shorter time was required to remove drain, hence reducing duration of in-hospital stay.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The use of locally injected TXA whilst performing subcutaneous surgery on patients taking antithrombotic drugs is cost-effective. It could reduce bleeding and provide a more effective surgical field. In our study, favorable results were obtained from the use of diluted tranexamic acid (1\u2009mg\/mL) mixed with lidocaine, namely in clearing the surgical field as well as reducing postoperative surgical complications.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000034900","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T21:00:40Z","timestamp":1693602040000},"page":"e34900","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy of local infiltration of tranexamic acid in subcutaneous surgery: A protocol from a single medical center"],"prefix":"10.1097","volume":"102","author":[{"given":"Yao-Jen","family":"Chang","sequence":"first","affiliation":[{"name":"Division of Plastic Surgery, Department of Surgery, Shin Kong Wu Ho-Su Memorial Hospital, Shilin District, Taipei, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hsien","family":"Lin","sequence":"additional","affiliation":[{"name":"Division of Plastic Surgery, Department of Surgery, Shin Kong Wu Ho-Su Memorial Hospital, Shilin District, Taipei, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pao-Lo","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Plastic Surgery, Department of Surgery, Shin Kong Wu Ho-Su Memorial Hospital, Shilin District, Taipei, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9502-7452","authenticated-orcid":false,"given":"Hwang-Chi","family":"Lin","sequence":"additional","affiliation":[{"name":"Division of Plastic Surgery, Department of Surgery, Shin Kong Wu Ho-Su Memorial Hospital, Shilin District, Taipei, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/ALN.0b013e3181e08e97","article-title":"Anemia and patient blood management in hip and knee surgery: a systematic review of the literature.","volume":"113","author":"Spahn","year":"2010","journal-title":"Anesthesiology"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s00167-014-2898-4","article-title":"Fibrin sealant before wound closure in total knee arthroplasty reduced blood loss: a meta-analysis.","volume":"23","author":"Li","year":"2015","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.thromres.2008.09.015","article-title":"Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials.","volume":"123","author":"Kagoma","year":"2009","journal-title":"Thromb Res"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1445-2197.1970.tb05387.x","article-title":"The use of electro cutting and electrocoagulation in surgery.","volume":"39","author":"Lawrenson","year":"1970","journal-title":"Aust N Z J Surg"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0002-9610(05)80757-3","article-title":"Effect of electrocautery on wound healing in midline laparotomy incisions.","volume":"160","author":"Rappaport","year":"1990","journal-title":"Am J Surg"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2165\/00003495-199957060-00017","article-title":"Tranexamic acid: a review of its use in surgery and other indications.","volume":"57","author":"Dunn","year":"1999","journal-title":"Drugs"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00004311-199500000-00009","article-title":"Blood-sparing drugs: aprotinin, tranexamic acid, and epsilon aminocaproic acid.","volume":"33","author":"Royston","year":"1995","journal-title":"Int Anesthesiol Clin"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jclinane.2019.04.006","article-title":"Cost-benefit analysis of the use of tranexamic acid in total replacement hip surgery.","volume":"57","author":"Lopez-Picado","year":"2019","journal-title":"J Clin Anesth"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/s13054-021-03799-9","article-title":"Effect of tranexamic acid on thrombotic events and seizures in bleeding patients: a systematic review and meta-analysis.","volume":"25","author":"Murao","year":"2021","journal-title":"Crit Care"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH- 2): a randomised, placebo-controlled trial.","volume":"376","author":"Shakur","year":"2010","journal-title":"Lancet"},{"key":"R12-20250504","first-page":"527","article-title":"The effects of locally injectedly applied tranexamic acid on reduction of postlaminectomy hemorrhage.","volume":"68","author":"Saberi","year":"2010","journal-title":"Tehran Univ Med J"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2165\/11209070-000000000-00000","article-title":"Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis.","volume":"72","author":"McCormack","year":"2012","journal-title":"Drugs"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.2106\/JBJS.I.01518","article-title":"Locally injected application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.","volume":"92","author":"Wong","year":"2010","journal-title":"J Bone Joint Surg Am"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/1471-2474-14-340","article-title":"Efficacy of low-dose intra-articular tranexamic acid in total knee replacement; a prospective triple-blinded randomized controlled trial.","volume":"14","author":"Sa-Ngasoongsong","year":"2013","journal-title":"BMC Musculoskelet Disord"},{"key":"R16-20250504","first-page":"CD010562","article-title":"Locally injected application of tranexamic acid for the reduction of bleeding.","volume":"7","author":"Ker","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1007\/s11999-013-3446-0","article-title":"Locally injected tranexamic acid reduces blood loss and transfusion rates associated with primary total hip arthroplasty.","volume":"472","author":"Chang","year":"2014","journal-title":"Clin Orthop Relat Res"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/DSS.0000000000001786","article-title":"Subcutaneous injection of tranexamic acid to reduce bleeding during dermatologic surgery: a double-blind, placebo-controlled, randomized clinical trial.","volume":"45","author":"Zilinsky","year":"2019","journal-title":"Dermatol Surg"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.ijporl.2013.04.021","article-title":"Locally injected application of tranexamic acid after adenoidectomy: a double-blind, prospective, randomized, controlled study.","volume":"77","author":"Albirmawy","year":"2013","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/fpsam.2020.0061","article-title":"Effect of local tranexamic acid on hemostasis in rhytidectomy.","volume":"22","author":"Schroeder","year":"2020","journal-title":"Facial Plast Surg Aesthet Med"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/asj\/sjz232","article-title":"Local infiltration of tranexamic acid with local anesthetic reduces intraoperative facelift bleeding: a preliminary report.","volume":"40","author":"Couto","year":"2020","journal-title":"Aesthet Surg J"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.tmrv.2018.02.003","article-title":"The efficacy and safety of topical tranexamic acid: a systematic review and meta-analysis.","volume":"32","author":"Montroy","year":"2018","journal-title":"Transfus Med Rev"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/PRS.0000000000008884","article-title":"Safety and efficacy of local tranexamic acid for the prevention of surgical bleeding in soft-tissue surgery: a review of the literature and recommendations for plastic surgery.","volume":"149","author":"Ausen","year":"2022","journal-title":"Plast Reconstr Surg"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"e104477","DOI":"10.1371\/journal.pone.0104477","article-title":"Effect of topical tranexamic acid on bleeding and quality of surgical field during functional endoscopic sinus surgery in patients with chronic rhinosinusitis: a triple blind randomized clinical trial.","volume":"9","author":"Jahanshahi","year":"2014","journal-title":"PLoS One"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"1683414","DOI":"10.1155\/2018\/1683414","article-title":"Tranexamic acid for adults with melasma: a systematic review and meta-analysis.","volume":"2018","author":"Zhang","year":"2018","journal-title":"Biomed Res Int"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1169e","DOI":"10.1097\/PRS.0000000000005620","article-title":"Serum concentrations and pharmacokinetics of tranexamic acid after two means of topical administration in massive weight loss skin-reducing surgery.","volume":"143","author":"Ausen","year":"2019","journal-title":"Plast Reconstr Surg"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/EJA.0000000000000316","article-title":"Effective tranexamic acid concentration for 95% inhibition of tissue type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease: a prospective, controlled, in-vitro study.","volume":"32","author":"Rozen","year":"2015","journal-title":"Eur J Anaesthesiol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1213\/ANE.0b013e3182a22258","article-title":"The effective concentration of tranexamic acid for inhibition of fibrinolysis in neonatal plasma in vitro.","volume":"117","author":"Yee","year":"2013","journal-title":"Anesth Analg"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1749-6632.1968.tb20322.x","article-title":"Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA.","volume":"146","author":"Andersson","year":"1968","journal-title":"Ann N Y Acad Sci"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1177\/0394632016671142","article-title":"Effects of tranexamic acid on coagulation indexes of patients undergoing heart valve replacement surgery under cardiopulmonary bypass.","volume":"29","author":"Liu","year":"2016","journal-title":"Int J Immunopathol Pharmacol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"7403034","DOI":"10.1155\/2020\/7403034","article-title":"Comparison of intravenous versus topical tranexamic acid in nondeformity spine surgery: a meta-analysis.","volume":"2020","author":"Xiong","year":"2020","journal-title":"Biomed Res Int"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034900","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:11:25Z","timestamp":1746324685000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":30,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000034900","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,1]]}}}